Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-05-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
- Kindhedge funds, private equity
- Others nearbyNew York, NY, Palo Alto, CA
As an employer
- Offices in1 country
- Private fundshedge 1, private equity 6
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 11 |
| Palo Alto, CAUnited States |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$2.1bn
reported value
+44.2% vs Q4 2023
38positions
63.6%in top 10
9 new
14 added
6 reduced
7 sold out
vs Q4 2023
Holdings, Q1 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $564.4m26.85% | Unchanged |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $140.2m6.67% | Added +976.0k |
| OCULAR THERAPEUTIX INC OCUL | $116.1m5.52% | Added +5.0m |
| SPYRE THERAPEUTICS INC SYRE | $82.4m3.92% | Reduced -200.9k |
| MERUS N V MRUS | $80.6m3.83% | Reduced -358.0k |
| PHARVARIS N V PHVS | $78.5m3.73% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $74.1m3.53% | Added +2.2m |
| ENLIVEN THERAPEUTICS INC ELVN | $70.8m3.37% | Added +1.1m |
| VIRIDIAN THERAPEUTICS INC VRDN | $68.0m3.23% | Added +48 |
| DIANTHUS THERAPEUTICS INC DNTH | $62.8m2.99% | Added +1.2m |
| DYNE THERAPEUTICS INC DYN | $61.7m2.94% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $61.7m2.94% | Added +2.8m |
| ORIC PHARMACEUTICALS INC ORIC | $60.4m2.87% | Added +2.0m |
| ASTRIA THERAPEUTICS INC CATB | $50.8m2.42% | Added +382.8k |
| MERSANA THERAPEUTICS INC COM | $50.7m2.41% | Unchanged |
| ENGENE HOLDINGS INC COM | $43.5m2.07% | New |
| PRAXIS PRECISION MEDICINES I PRAX | $43.1m2.05% | Added +352.5k |
| HILLEVAX INC COM | $34.5m1.64% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $34.5m1.64% | Added +445.0k |
| EDGEWISE THERAPEUTICS INC EWTX | $33.2m1.58% | New |
| CABALETTA BIO INC CABA | $26.7m1.27% | Reduced -1.0m |
| ARVINAS INC ARVN | $25.9m1.23% | Unchanged |
| TAYSHA GENE THERAPIES INC TSHA | $25.8m1.23% | Reduced -1.4m |
| AQUESTIVE THERAPEUTICS INC AQST | $23.7m1.13% | New |
| TERNS PHARMACEUTICALS INC COM | $22.4m1.06% | Reduced -1.1m |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $22.0m1.05% | New |
| CELCUITY INC CELC | $21.0m1.00% | Reduced -915.5k |
| ABIVAX SA ABVX | $19.2m0.92% | Added +347.2k |
| IMMATICS N.V IMTX | $18.4m0.87% | New |
| LYRA THERAPEUTICS INC LYRA | $16.0m0.76% | Added +500 |
| CG ONCOLOGY INC CGON | $15.4m0.73% | New |
| CENTURY THERAPEUTICS INC IPSC | $14.2m0.68% | New |
| TREVI THERAPEUTICS INC TRVI | $11.8m0.56% | Added +278 |
| TENAYA THERAPEUTICS INC TNYA | $8.1m0.39% | New |
| MINERALYS THERAPEUTICS INC MLYS | $7.2m0.34% | New |
| ACELYRIN INC COM | $6.3m0.30% | Unchanged |
| EYEPOINT PHARMACEUTICALS INC EYPT | $5.2m0.25% | Unchanged |
| OLEMA PHARMACEUTICALS INC OLMA | $872.1k0.04% | Unchanged |
Sold out since Q4 2023
| Security | Value then |
|---|---|
| RAYZEBIO INC | $250.6m4.0m shares |
| AMBRX BIOPHARMA INC | $29.5m2.1m shares |
| RHYTHM PHARMACEUTICALS INC RYTM | $22.8m496.0k shares |
| SAVARA INC SVRA | $16.4m3.5m shares |
| GH RESEARCH PLC GHRS | $7.6m1.3m shares |
| ADVERUM BIOTECHNOLOGIES INC | $3.9m5.1m shares |
| MILESTONE PHARMACEUTICALS IN MIST | $1.5m925.0k shares |